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Abstract
Background: The occurence of cholesteatoma and cochlear implant is rare. Secondary cholesteatomas may
develop as a result of cochlear implant surgery. Primarily acquired cholesteatoma is not typically associated
with congenital sensorineural hearing loss or cochlear implant in children. The occurrence of congenital
cholesteatoma during cochlear implant surgery has never been reported before, partly because all patients
are preoperatively submitted to imaging studies which can theoretically exclude the disease.
Case presentation: We have reported a rare case of congenital cholesteatoma, found during sequential
second side cochlear implantation in a 3-year-old child. The child underwent a computed tomography (CT)
scan and magnetic resonance imaging (MRI) at 12 months of age, before the first cochlear implant surgery,
which excluded middle ear pathology. The mass was removed as an intact pearl, without visible or microscopic
violation of the cholesteatoma capsule. All the areas where middle ear structures were touching the cholesteatoma
were vaporized with a laser and the cochlear implant was inserted uneventfully. Further follow-up excluded
residual disease.
Conclusion: We believe that primary, single stage placement of a cochlear implant (CI) with simultaneous
removal of the congenital cholesteatoma can be performed safely. However, to prevent recurrence, the capsule of the
cholesteatoma must not be damaged and complete laser ablation of the surface, where suspicious epithelial
cells could remain, is recommended. In our opinion, cholesteatoma removal and cochlear implantation should
be staged if these conditions are not met, and/or the disease is at a more advanced stage. It is suspected,
that the incidence of congenital cholesteatoma in pediatric CI candidates is much higher that in average
pediatric population.
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Background
Cholesteatoma is an uncommon condition that has been
rarely associated with cochlear implantation. Primary
acquired cholesteatoma is not typically associated with
congenital sensorineural hearing loss (SNHL) or CI in
children. In case of secondary acquired cholesteatomas –
they can develop as the result of cochlear implant surgery
due to a breach of the posterior wall of the ear canal from
drilling the posterior tympanotomy [1]. The identification
of congenital cholesteatoma during CI surgery is unlikely
because of thorough pre-operative imaging studies, most
commonly involving high-resolution computed tomog-
raphy (HRCT) and MRI of the temporal bone, which
can theoretically exclude congenital cholesteatoma.
The incidence of congenital cholesteatoma in the
overall population is 0.00012 % and 1–3 % of childhood
cholesteatomas are congenital [2, 3]. Chung et al. re-
ported that congenital cholesteatoma was identified in
2 out of 794 pediatric CI patients during their pre-
operative evaluations for CI (incidence, 0.25 %) [4]. The
authors suggest that the incidence was much higher than
expected of this rare condition.
Congenital cholesteatoma was initially described by
Cawthorne and Griffith [5]. In 1965, Derlacki and
Clemis defined congenital cholesteatoma as an em-
bryologic residue of epithelial tissue behind a normal
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tympanic membrane in the absence of a history of in-
fection or ear surgery [6]. Levenson added that the
presence of uncomplicated acute otitis media does
not exclude congenital cholesteatoma [7].
Congenital cholesteatoma usually grows slowly as a
spherical-shaped keratin-filled cyst in the middle ear
with a long asymptomatic period. When early detected,
they are located deep to the antero-superior part of the
tympanic membrane in two-thirds of the cases. The
diagnosis is made at an average age of 4.5 years with a
male to female ratio of 1:3. There are two types of con-
genital cholesteatoma, defined according to their loca-
tion in the middle ear. The first is an isolated pearl
located deep to the anterior part of the eardrum, which
is believed to result from arrested epidermal formation
at 10 weeks’ gestational age. It is suggested that these
formations atrophy at approximately 33 weeks of gesta-
tional age, or are evacuated through the Eustachian tube.
Failure of this mechanism results in this type of congeni-
tal cholesteatoma [8]. The second type is located in the
posterior part of the middle ear and causes more rapid os-
sicular destruction and hearing impairment. The origin of
this type is thought to be amniotic fluid cells that migrate
in the neonate [9]. The theory of congenital cholesteatoma
origin assumes that the pathology is present before birth
and the diagnosis is most often made by a combination of
otoscopy and HRCT. In a completely aerated tympanic
cavity absent of any associated soft tissue, HRCT has a
high negative predictive value when excluding cholestea-
toma [10]. Microsurgical excision is the accepted treat-
ment and associated laser vaporization of contact points
has been shown to limit the rate of recurrence [11]. We
present a case of congenital cholesteatoma found this time
not during diagnostic procedure before CI, but during se-
quential second side cochlear implantation in a 3-year-old
child in spite of prior imaging studies.
Case presentation
The patient was a female child diagnosed with bilateral
SNHL of genetic origin at the age of 8 months. Genetic
testing identified a deletion - 35delG in gene GJB2. The
patient failed the newborn hearing screen at birth with
subsequent diagnostic auditory brainstem responses
demonstrating bilateral, severe to profound SNHL. The
child initially received hearing aids but presented signifi-
cant speech delay despite conventional amplification.
Referred for consideration for CI, the patient underwent
thorough diagnostic testing by a multidisciplinary team
as well as imaging evaluation with HRCT and MRI.
HRCT of the temporal bones was performed with a
standard protocol using a bone algorithm with a slice
thickness of 0.625 mm and collimation of 0.3 mm.
Preoperative 1.5 Tesla MRI (Fig. 1) and HRCT (Fig. 2)
studies showed implantable inner ear spaces, present
cochlear nerves, and no suggestion of additional middle
ear pathology. A decision was made to implant the right
ear and surgery was performed when the child reached
1 year of age. The surgery on this side was uneventful
and without complications or findings of associated
middle ear diseases. At the same time, the left ear
was equipped with an updated hearing aid. The Inte-
gration Scale of Development was used to assess the
development of hearing and speech, which is our rou-
tine protocol for children between 1 and 4 years of
age. The results showed that the child achieved excel-
lent speech and language outcomes comparable to
age-appropriate normal hearing subjects. The patient
was subsequently evaluated for sequential implant-
ation of the left ear, showing unremarkable otoscopy
and a normal tympanic membrane. Normal appear-
ance of the tympanic membrane was also confirmed
during otomicroscopy intraoperatively at the time of
the second CI surgery. The second implantation was
performed two years after the first CI surgery when
the child was 3 years old. In our clinic, in cases of
sequential implantation, we do not routinely re-image
the temporal bones if the first examination showed
no pathology. The second CI surgery was performed
as per our routine protocol using a posterior tympa-
notomy approach to the round window and promon-
tory. After opening the facial recess, an approximately
3-mm pearl-appearing cholesteatoma was identified
between the facial ridge, incudostapedial joint, and
cochleariform process (Fig. 3). To remove the path-
ology en bloc, the ossicles were disarticulated and the
cholesteatoma was removed together with the incus.
All tissues contacting the cholesteatoma were vapor-
ized superficially with a diode laser at a setting of
2 W with single short pulses of 0.05 s (Fig. 4) delivered
through a 0.6-mm fiber. In surgery for isolated cholestea-
toma pearls, we routinely use a laser to minimize the risk
of recurrence. The CI was then inserted uneventfully
through an extended round window approach.
One year after, a CT of the temporal bone was
performed to exclude residual disease and suspicious
opacification in the facial recess area was revealed.
Fig. 1 MRI T2-weighted axial image of the ear before the first CI
surgery at 1 year of age showing no middle ear pathology
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The residual disease was excluded by the endoscopy
of the middle ear through anterior tympanotomy ap-
proach. The opacification turned out to be connective
tissue used for obliteration of posterior tympanotomy
during the CI surgery.
Discussion
Imaging before cochlear implantation is used to confirm
the presence of an implantable inner ear space and
intact cochlear nerve, as well as to provide important in-
formation about the surgical anatomy of the ear [12].
Both MRI and HRCT can potentially diagnose a patho-
logic mass such as cholesteatoma in the middle ear
space. HRCT has excellent sub-millimeter spatial reso-
lution, which provides accurate delineation of even very
small cholesteatomas, as long as there is a well-
aerated middle ear cavity. HRCT in this setting offers
high sensitivity and excellent negative predictive value
[13]. In our case, the conditions for evaluation of the
middle ear were excellent. The middle ear was com-
pletely free of effusion (Fig. 2), however HRCT has
poor specificity because the nature of the soft tissue
density cannot be differentiated.
MRI using the conventional sequences (T1-weighted
image, T2-weighted image, post-contrast T1-weighted
image) provides additional information enabling dis-
tinguishment of different pathologic entities, as well
as accurate diagnosis of primary and residual/recur-
rent cholesteatomas. Even higher diagnostic specificity
is achieved with diffusion-weighted (DW) echo-planar
Fig. 2 HRCT image (axial-left and coronal-right) of the left temporal bone before the first CI surgery at 1 year of age showing no middle ear pathology
Fig. 3 Cholesteatoma, microscopic view Fig. 4 Diode laser treatment of the operated field, microscopic view
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imaging, delayed post-contrast imaging, DW-non-echo-
planar imaging, and DWI-PROPELLER techniques. We
used a 1.5 Tesla MRI with conventional sequences in our
patient, following our routine protocol, which was focused
primarily on assessing the anatomical implant feasibility in
young children. However, even with conventional proto-
cols, a pathological mass greater than 2 mm in size and
surrounded by air can be identified on the T2-weighted
sequence. In conventional MRI, the diagnosis of sub-
millimeter anatomical structures is also possible provided
that there is good signal contrast between the structure
and its surroundings, as in our case. For temporal bone
diagnosis in clinical practice, we use a 1.5 Tesla MRI.
With the development of new models, MRI at 3 Tesla
or higher is becoming more common and widely avail-
able. The main advantage is shorter acquisition time
but because of artifacts specific to this anatomic region,
diffusion-weighted sequence acquisition is paradoxically
longer, which increases the risk of motion artifacts, es-
pecially in children, making interpretation more diffi-
cult, even for experienced radiologists [14].
Except for paper of Chung et al., to date, there has
been no literature published on the incidence of con-
genital cholesteatoma found prior to implantation [4].
The authors found this incidence (0,25 %) much higher
than expected of this rare condition in general popula-
tion (0.00012 %). It is surprisingly common, given the
absence of any cases of primarily acquired cholesteatoma
in the reported group of patients, which is considerably
more common in the pediatric population. Our case, as
well as both reported by Chung et al. of congenital cho-
lesteatoma patients, most likely had an inherited form of
hearing loss and, as they suggested, genetic contribution
to the presence of congenital cholesteatoma cannot be
excluded [4]. A correlation between the formation of
congenital cholesteatoma and abnormal cochleovestibu-
lar anatomy and SNHL have also been reported by
Propst et al. and Jackler et al. [15, 16].
It has been suggested that if congenital cholesteatoma
is found during diagnostic procedures for CI, the choles-
teatoma should be removed and implantation delayed to
the second stage [4]. In our patient, we made the deci-
sion to remove the cholesteatoma and insert an implant
in a one-stage procedure because the disease was re-
moved as an intact pearl, without visible or microscopic
violation of the cholesteatoma capsule, and the areas of
contact between the cholesteatoma and middle ear
structures were vaporized with a laser. The risk of recur-
rence was very unlikely. Such a protocol has been used
in our clinic for several years in numerous ear opera-
tions, in cases of limited congenital cholesteatoma and
small cholesteatoma pearls found during second-look
procedures. We consider the procedure safe and do not
hesitate to proceed with ossicular reconstruction in such
cases. What is more, revision surgery is also not planned
in such situations.
Although the laser is not universally utilized in the
treatment of cholesteatoma, Hamilton concludes that
the appropriate use of the laser during cholesteatoma
surgery facilitates significantly the complete removal of
the disease and presents no extra risk to the vital struc-
tures within the temporal bone [11]. Also James et al.
stated that current technological advances such as laser
and middle ear endoscopy contribute to better outcomes
in the treatment of cholesteatoma [17]. As it has been
mentioned we routinely use laser during cholesteatoma
surgery in our clinic.
It has long been recognized that a second-look pro-
cedure in cases of congenital cholesteatoma is required
less often than in acquired pediatric cholesteatoma [18].
James et al. suggested that when the cholesteatoma cyst
is removed intact, complete eradication can be almost
guaranteed, and recommended a second-look procedure
when cholesteatoma extends into hidden regions such as
the mastoid, or with concerns about the completeness of
matrix removal [17]. We also follow this strategy. In our
case, the cholesteatoma did not extend into hidden
spaces; it was a closed capsule and we had no concerns
about incomplete removal. It should be emphasized that
the decision to proceed with CI requires careful consid-
eration on a case-by-case basis. Particularly with a larger
congenital cholesteatoma, a damaged capsule, or wide-
spread pathology, delaying CI is the most reasonable and
safest option [4].
According to Derlacki and Clemis’ criteria the patient’s
cholesteatoma met the definition of a congenital choles-
teatoma - it was totally asymptomatic and behind an in-
tact tympanic membrane [6]. Cholesteatoma was not
seen at otoscopy before the first and second surgery. Be-
fore the first surgery it was most probably so small that
it was not within the limits of visibility even for CT and
MRI. The cholesteatoma was not seen at otoscopy at the
second surgery either because it was located medially to
the long crus of the incus and the handle of the malleus.
Middle ear pathology located in the posterior mesotym-
panum is practically invisible until it touches the tym-
panic membrane and can be easily overlooked.
The growth rate of this particular cholesteatoma had
to be relatively dynamic.
The original size of the cholesteatoma is important.
According to the first theory of origination of congenital
cholesteatoma, the diameter of the epidermoid forma-
tions frequently found in human fetuses that proceed to
congenital cholesteatoma if not absorbed or evacuated
through the Eustachian tube, is already known. Huang et
al. reviewed 49 fetuses, ranging from 12 weeks to full
term. In 16 they found epidermoid formation, which was
always located at the anterosuperior edge of the eardrum
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[19]. The width and height of the epidermoid formations
was 60.82 ± 5.68 microns and 45.87 ± 6.82 microns, re-
spectively. In our case, the cholesteatoma was located in
the posterior mesotympanum, and met the second the-
ory of origination, which says that amniotic fluid cells
migrate through the Eustachian tube to the middle ear
and then form the cholesteatoma. In this case, the cho-
lesteatoma might have arisen from a single cell, or group
of cells, also microns in diameter.
Assuming a linear growth for congenital cholestea-
toma, James et al. calculated that closed cholesteatoma
cysts enlarge by approximately 1 mm in diameter per
year, based on CT measurements ([20] James). We can
assume in our case that the growth was linear because it
was a closed round capsule; therefore, in the first year of
life, theoretically, the cholesteatoma would have been
approximately 1 mm in diameter, enlarging to approxi-
mately 3 mm in diameter at 3 years of age. A 1-mm
pearl would be visible by imaging studies and the nega-
tive predictive value of CT in such a case is excellent [6].
The explanation for the lack of identification of the
cholesteatoma on the initial HRCT is that the pathology
was too small to be visualized. The most likely it was a
very small sub-millimeter “sleeper” congenital cholestea-
toma with no growth between birth and the first year,
but with subsequent rapid growth between 1 and 3 years
of life.
Bilateral cochlear implantation in young children is
increasingly common in clinical practice. Among the
benefits of bilateral cochlear implantation is the res-
toration of some of the advantages of binaural hear-
ing such as localization, improved listening in noise,
directional hearing, binaural summation, and squelch.
Typically, young hearing-impaired children are being
provided with two implants either at the same time
(simultaneous implantation) or at different times in early
childhood as in our case (sequential implantation) [21].
Our local public funding policy enables children to
receive initially unilateral cochlear implant due to
economic limitations. In our clinic, excluding the post
meningitis deafness, when bilateral implants are put
simultaneously, the CI candidates are implanted uni-
laterally as quickly as possible, starting from the age
of 12 months. Only when we are able to provide all
candidates with one implant and meet the economic
limitations, do we consider giving another implant to
prior pediatric CI users.
Examining the findings in this patient, the obvious
question arises whether to perform another imaging
study which could preclude the existing, newly formed
cholesteatoma before the subsequent CI surgery, and
how much time should elapse between the first and
second implantation, to perform such a study most
effectively?
We believe that the rarity of our particular case does
not justify the additional cost and burden of repeating
the standard HRCT and/or MRI in so young children.
Also, our case presented with limited pathology that was
controlled by a single-stage procedure. We emphasize
the importance of continued follow-up and advise con-
sidering staging in either known disease or more exten-
sive disease as a reasonable and safe option.
Conclusions
To our knowledge, this is the first report of an incidental
finding of congenital cholesteatoma during CI surgery
despite presurgical imaging studies. Primary excision en
bloc with the removal of associated ossicular elements
and laser surface ablation is the recommended treatment
for limited congenital cholesteatoma. Primary placement
of an implant during cholesteatoma removal is war-
ranted as long as there is insignificant risk of recurrence,
provided that no damage of the capsule has occurred
and complete and safe surface contact of epithelial laser
ablation was observed. There should be a low threshold
for staging the implant if any of these conditions are not
met, and/or the disease is found to be more extensive.
Follow-up should include regular microscopic ear exam-
ination and HRCT.
There is suspicion that the incidence of congenital
cholesteatoma in pediatric CI candidates is much higher
than in normal pediatric population (4).
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